Human recombinant anti-HER2 monoclonal antibody--a new targeted treatment in breast cancer;Rekombináns humán anti-HER2 monoklonális antitest--egy új célzott terápia az emlórák kezelésében.

Orvosi hetilap

Volumn 142, Issue 46, 2001, Pages 2563-2568

  Dank, M ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR 2; MONOCLONAL ANTIBODY; TRASTUZUMAB;

BREAST TUMOR; DISEASE FREE SURVIVAL; DRUG EFFECT; FEMALE; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; REVIEW; TREATMENT OUTCOME; UPREGULATION;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; RECEPTOR, ERBB-2; TREATMENT OUTCOME; UP-REGULATION;

EID: 17144440510     PISSN: 00306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)